Who owns HALOZYME THERAPEUTICS INC NOTE 1.000 8/1?
- CUSIP Number: 40637haf6
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics Inc Note 1.000 8/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics Inc Note 1.000 8/1 stock
Who bought or sold HALOZYME THERAPEUTICS INC NOTE 1.000 8/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tenor Capital Management | 55M | $71M | 39% | Mar 2026 |
|
| Point72 Asset Management | 47M | $61M | 16% | Mar 2026 |
|
| LMR Partners | 45M | $58M | 11% | Mar 2026 |
|
| Alberta Investment Management Corporation | 35M | $45M | 0% | Mar 2026 |
|
| Millennium Management | 29M | $37M | 45% | Mar 2026 |
|
| Citadel Advisors | 25M | $32M | 6% | Mar 2026 |
|
| Balyasny Asset Management | 18M | $23M | 20% | Mar 2026 |
|
| Lazard Asset Management | 16M | $207k | -5% | Mar 2026 |
|
| Lombard Odier Asset Management | 16M | $21M | 100% | Dec 2025 |
|
| Absolute Investment Advisers | 14M | $18M | 0% | Mar 2026 |
|
| Linden Advisors | 13M | $17M | 0% | Dec 2025 |
|
| Calamos Advisors | 12M | $15M | -1% | Mar 2026 |
|
| State Street Corporation | 9.6M | $13M | -32% | Dec 2025 |
|
| Franklin Resources | 8.4M | $11M | 3% | Mar 2026 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 8.1M | $10M | 0% | Mar 2026 |
|
| Advent Capital Management | 7.9M | $10M | 3291% | Mar 2026 |
|
| BlackRock | 7.6M | $9.8M | 33% | Mar 2026 |
|
| Ofi Invest Asset Management | 6.8M | $7.6M | 0% | Mar 2026 |
|
| FMR | 6.7M | $8.8M | -30% | Dec 2025 |
|
| Invesco | 6.5M | $8.3M | 44% | Mar 2026 |
|
| Wells Fargo & Company | 6.1M | $7.9M | -37% | Mar 2026 |
|
| SSI Investment Management | 6.1M | $7.8M | 0% | Mar 2026 |
|
| Warberg Asset Management | 6.0M | $7.7M | -25% | Mar 2026 |
|
| Ing Investment Management | 6.0M | $7.7M | 100% | Mar 2026 |
|
| Bank Of Montreal | 6.0M | $7.7M | 100% | Mar 2026 |
|
| Union Bancaire Privee, UBP SA | 4.2M | $4.5M | -12% | Mar 2026 |
|
| State of Wisconsin Investment Board | 3.0M | $4.0M | 0% | Dec 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 2.6M | $3.3M | 0% | Mar 2026 |
|
| Morgan Stanley | 2.4M | $3.1M | -75% | Mar 2026 |
|
| Colony | 2.3M | $3.0M | 100% | Dec 2025 |
|
| Capital World Investors | 2.2M | $2.8M | 0% | Mar 2026 |
|
| Bank of America Corporation | 2.1M | $2.7M | 100% | Mar 2026 |
|
| Agf Management | 1.5M | $1.9M | 0% | Mar 2026 |
|
| Barclays | 1.2M | $1.6M | -6% | Dec 2025 |
|
| Palisade Capital Management | 1.1M | $1.4M | -1% | Dec 2025 |
|
| Goldman Sachs Group | 900k | $1.2M | 0% | Mar 2026 |
|
| Dnca Finance | 630k | $839k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 610k | $786k | 0% | Mar 2026 |
|
| Zurcher Kantonalbank | 500k | $638k | -29% | Mar 2026 |
|
| Man Group | 370k | $477k | -78% | Mar 2026 |
|
| Royal Bank of Canada | 366k | $471k | 14% | Mar 2026 |
|
| Central Pacific Bank - Trust Division | 317k | $406k | 0% | Mar 2026 |
|
| Russell Investments | 232k | $299k | 0% | Mar 2026 |
|
| Jane Street | 118k | $153k | 100% | Mar 2026 |
|
| Ares Systematic Credit | 100k | $125k | 0% | Mar 2026 |
|
| Virtus ETF Advisers | 35k | $45k | -46% | Mar 2026 |
|
| Steward Partners Investment Advisory | 6.0k | $7.7k | 0% | Mar 2026 |
|
| Us Bancorp | 5.0k | $6.6k | 0% | Dec 2025 |
|
| Loomis, Sayles and | 4.5k | $300k | 25% | Dec 2025 |
|
| Alken Asset Management | 2.0k | $2.6M | 0% | Mar 2026 |
|
| UBS Group | 1.3k | $1.7k | 0% | Mar 2026 |
|
Who sold out of Halozyme Therapeutics Inc Note 1.000 8/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jain Global | Dec 2025 | 25M | $33M |
| Jpmorgan Chase & Co | Sep 2025 | 22M | $31M |
| UBS O'Connor | Sep 2025 | 7.0M | $9.9M |
| Susquehanna Advisors Group | Sep 2025 | 5.0M | $70k |
| Lord, Abbett & Co | Dec 2025 | 3.7M | $4.9M |
| Walleye Trading Advisors | Dec 2025 | 3.0M | $4.0M |
| Groupama Asset Managment | Dec 2025 | 2.0M | $2.7M |
| Toronto-Dominion Bank | Sep 2025 | 1.7M | $2.4M |
| Deutsche Bank Aktiengesellschaft | Dec 2025 | 1.4M | $1.9M |
| Prospector Partners | Sep 2025 | 1.2M | $1.7M |
| Leucadia National Corporation | Dec 2025 | 1.2M | $1.6M |
| Boussard & Gavaudan Investment Management | Sep 2025 | 2.1k | $3.0M |